CD68 and metabolic dysfunction-associated steatohepatitis: In human NASH, accumulation of CD68+ cells in the liver increase with disease stage [53] and macrophages (in particular Kupffer cells) play an important role in the progression towards NASH and present potential pharmacological targets [54, 55].